nodes	percent_of_prediction	percent_of_DWPC	metapath
Methantheline—HRH2—Class A/1 (Rhodopsin-like receptors)—F2—atherosclerosis	0.00228	0.00228	CbGpPWpGaD
Methantheline—HRH2—GPCR ligand binding—EDN1—atherosclerosis	0.00227	0.00227	CbGpPWpGaD
Methantheline—HRH2—GPCR ligand binding—CCL5—atherosclerosis	0.00225	0.00225	CbGpPWpGaD
Methantheline—CHRM1—Regulation of Actin Cytoskeleton—PDGFB—atherosclerosis	0.00224	0.00224	CbGpPWpGaD
Methantheline—HRH2—Signaling by GPCR—CX3CR1—atherosclerosis	0.00223	0.00223	CbGpPWpGaD
Methantheline—HRH2—Signaling by GPCR—CASR—atherosclerosis	0.00223	0.00223	CbGpPWpGaD
Methantheline—CHRM1—Class A/1 (Rhodopsin-like receptors)—CCL3—atherosclerosis	0.00223	0.00223	CbGpPWpGaD
Methantheline—CHRM1—GPCR ligand binding—UTS2—atherosclerosis	0.00221	0.00221	CbGpPWpGaD
Methantheline—CHRM1—G alpha (q) signalling events—EDN1—atherosclerosis	0.00219	0.00219	CbGpPWpGaD
Methantheline—HRH2—Signaling by GPCR—CX3CL1—atherosclerosis	0.00219	0.00219	CbGpPWpGaD
Methantheline—HRH2—Signaling Pathways—HRH1—atherosclerosis	0.00214	0.00214	CbGpPWpGaD
Methantheline—CHRM1—Circadian rythm related genes—SIRT1—atherosclerosis	0.00214	0.00214	CbGpPWpGaD
Methantheline—CHRM1—GPCR ligand binding—CX3CR1—atherosclerosis	0.00212	0.00212	CbGpPWpGaD
Methantheline—CHRM1—GPCR ligand binding—CASR—atherosclerosis	0.00212	0.00212	CbGpPWpGaD
Methantheline—CHRM1—GPCR ligand binding—CX3CL1—atherosclerosis	0.00208	0.00208	CbGpPWpGaD
Methantheline—HRH2—Signaling by GPCR—CNR2—atherosclerosis	0.00208	0.00208	CbGpPWpGaD
Methantheline—CHRM1—Gastrin-CREB signalling pathway via PKC and MAPK—MMP3—atherosclerosis	0.00206	0.00206	CbGpPWpGaD
Methantheline—HRH2—Class A/1 (Rhodopsin-like receptors)—CCL2—atherosclerosis	0.00204	0.00204	CbGpPWpGaD
Methantheline—CHRM1—Regulation of Actin Cytoskeleton—F2—atherosclerosis	0.00202	0.00202	CbGpPWpGaD
Methantheline—CHRM1—Class A/1 (Rhodopsin-like receptors)—EDNRA—atherosclerosis	0.00202	0.00202	CbGpPWpGaD
Methantheline—CHRM1—Class A/1 (Rhodopsin-like receptors)—CCR2—atherosclerosis	0.00202	0.00202	CbGpPWpGaD
Methantheline—CHRM1—GPCRs, Class A Rhodopsin-like—AGTR1—atherosclerosis	0.002	0.002	CbGpPWpGaD
Methantheline—CHRM1—GPCR ligand binding—CNR2—atherosclerosis	0.00197	0.00197	CbGpPWpGaD
Methantheline—CHRM1—Class A/1 (Rhodopsin-like receptors)—GHRL—atherosclerosis	0.00196	0.00196	CbGpPWpGaD
Methantheline—CHRM1—Gastrin-CREB signalling pathway via PKC and MAPK—EDN1—atherosclerosis	0.00196	0.00196	CbGpPWpGaD
Methantheline—CHRM1—Circadian rythm related genes—PRKCG—atherosclerosis	0.00195	0.00195	CbGpPWpGaD
Methantheline—CHRM1—GPCR downstream signaling—HRH1—atherosclerosis	0.00194	0.00194	CbGpPWpGaD
Methantheline—CHRM1—Regulation of Actin Cytoskeleton—PIK3CG—atherosclerosis	0.00193	0.00193	CbGpPWpGaD
Methantheline—HRH2—GPCR ligand binding—AGT—atherosclerosis	0.00188	0.00188	CbGpPWpGaD
Methantheline—CHRM1—G alpha (q) signalling events—AGT—atherosclerosis	0.00182	0.00182	CbGpPWpGaD
Methantheline—HRH2—Signaling by GPCR—CCL3—atherosclerosis	0.00179	0.00179	CbGpPWpGaD
Methantheline—HRH2—GPCR downstream signaling—CCR2—atherosclerosis	0.00178	0.00178	CbGpPWpGaD
Methantheline—HRH2—GPCR downstream signaling—EDNRA—atherosclerosis	0.00178	0.00178	CbGpPWpGaD
Methantheline—CHRM1—Circadian rythm related genes—PPARA—atherosclerosis	0.00177	0.00177	CbGpPWpGaD
Methantheline—CHRM1—Signaling by GPCR—HRH1—atherosclerosis	0.00176	0.00176	CbGpPWpGaD
Methantheline—HRH2—GPCR ligand binding—F2—atherosclerosis	0.00174	0.00174	CbGpPWpGaD
Methantheline—HRH2—GPCR downstream signaling—GHRL—atherosclerosis	0.00173	0.00173	CbGpPWpGaD
Methantheline—CHRM1—Class A/1 (Rhodopsin-like receptors)—KNG1—atherosclerosis	0.00172	0.00172	CbGpPWpGaD
Methantheline—CHRM1—Class A/1 (Rhodopsin-like receptors)—AGTR1—atherosclerosis	0.00171	0.00171	CbGpPWpGaD
Methantheline—CHRM1—GPCR ligand binding—CCL3—atherosclerosis	0.0017	0.0017	CbGpPWpGaD
Methantheline—CHRM1—Circadian rythm related genes—LEP—atherosclerosis	0.00168	0.00168	CbGpPWpGaD
Methantheline—CHRM1—G alpha (q) signalling events—F2—atherosclerosis	0.00168	0.00168	CbGpPWpGaD
Methantheline—HRH2—Signaling Pathways—APOA4—atherosclerosis	0.00168	0.00168	CbGpPWpGaD
Methantheline—CHRM1—Gastrin-CREB signalling pathway via PKC and MAPK—AGT—atherosclerosis	0.00163	0.00163	CbGpPWpGaD
Methantheline—HRH2—Signaling by GPCR—EDNRA—atherosclerosis	0.00161	0.00161	CbGpPWpGaD
Methantheline—HRH2—Signaling by GPCR—CCR2—atherosclerosis	0.00161	0.00161	CbGpPWpGaD
Methantheline—HRH2—Class A/1 (Rhodopsin-like receptors)—CXCL8—atherosclerosis	0.00161	0.00161	CbGpPWpGaD
Methantheline—HRH2—Signaling by GPCR—GHRL—atherosclerosis	0.00157	0.00157	CbGpPWpGaD
Methantheline—CHRM1—Circadian rythm related genes—NOS2—atherosclerosis	0.00157	0.00157	CbGpPWpGaD
Methantheline—HRH2—GPCR ligand binding—CCL2—atherosclerosis	0.00155	0.00155	CbGpPWpGaD
Methantheline—HRH2—Signaling Pathways—CCL4—atherosclerosis	0.00154	0.00154	CbGpPWpGaD
Methantheline—CHRM1—GPCR ligand binding—CCR2—atherosclerosis	0.00153	0.00153	CbGpPWpGaD
Methantheline—CHRM1—GPCR ligand binding—EDNRA—atherosclerosis	0.00153	0.00153	CbGpPWpGaD
Methantheline—HRH2—GPCR downstream signaling—KNG1—atherosclerosis	0.00152	0.00152	CbGpPWpGaD
Methantheline—HRH2—GPCR downstream signaling—AGTR1—atherosclerosis	0.00151	0.00151	CbGpPWpGaD
Methantheline—CHRM1—Gastrin-CREB signalling pathway via PKC and MAPK—F2—atherosclerosis	0.0015	0.0015	CbGpPWpGaD
Methantheline—CHRM1—GPCR ligand binding—GHRL—atherosclerosis	0.0015	0.0015	CbGpPWpGaD
Methantheline—CHRM1—Circadian rythm related genes—PPARG—atherosclerosis	0.00147	0.00147	CbGpPWpGaD
Methantheline—CHRM1—Class A/1 (Rhodopsin-like receptors)—EDN1—atherosclerosis	0.00145	0.00145	CbGpPWpGaD
Methantheline—HRH2—Signaling Pathways—APOA2—atherosclerosis	0.00144	0.00144	CbGpPWpGaD
Methantheline—CHRM1—Class A/1 (Rhodopsin-like receptors)—CCL5—atherosclerosis	0.00144	0.00144	CbGpPWpGaD
Methantheline—HRH2—Signaling by GPCR—KNG1—atherosclerosis	0.00138	0.00138	CbGpPWpGaD
Methantheline—HRH2—Signaling Pathways—UTS2—atherosclerosis	0.00138	0.00138	CbGpPWpGaD
Methantheline—HRH2—Signaling by GPCR—AGTR1—atherosclerosis	0.00137	0.00137	CbGpPWpGaD
Methantheline—CHRM1—Circadian rythm related genes—SERPINE1—atherosclerosis	0.00132	0.00132	CbGpPWpGaD
Methantheline—HRH2—Signaling Pathways—CX3CR1—atherosclerosis	0.00132	0.00132	CbGpPWpGaD
Methantheline—HRH2—Signaling Pathways—CASR—atherosclerosis	0.00132	0.00132	CbGpPWpGaD
Methantheline—CHRM1—GPCR ligand binding—KNG1—atherosclerosis	0.00131	0.00131	CbGpPWpGaD
Methantheline—CHRM1—GPCR ligand binding—AGTR1—atherosclerosis	0.00131	0.00131	CbGpPWpGaD
Methantheline—HRH2—Signaling Pathways—CX3CL1—atherosclerosis	0.00129	0.00129	CbGpPWpGaD
Methantheline—HRH2—GPCR downstream signaling—EDN1—atherosclerosis	0.00128	0.00128	CbGpPWpGaD
Methantheline—CHRM1—Signaling by GPCR—CCL4—atherosclerosis	0.00128	0.00128	CbGpPWpGaD
Methantheline—HRH2—GPCR downstream signaling—CCL5—atherosclerosis	0.00127	0.00127	CbGpPWpGaD
Methantheline—CHRM1—GPCR downstream signaling—UTS2—atherosclerosis	0.00125	0.00125	CbGpPWpGaD
Methantheline—HRH2—Signaling Pathways—CNR2—atherosclerosis	0.00123	0.00123	CbGpPWpGaD
Methantheline—HRH2—GPCR ligand binding—CXCL8—atherosclerosis	0.00123	0.00123	CbGpPWpGaD
Methantheline—HRH2—Signaling by GPCR—MMP3—atherosclerosis	0.00122	0.00122	CbGpPWpGaD
Methantheline—HRH2—GPCR downstream signaling—PRKCG—atherosclerosis	0.00121	0.00121	CbGpPWpGaD
Methantheline—CHRM1—Class A/1 (Rhodopsin-like receptors)—AGT—atherosclerosis	0.00121	0.00121	CbGpPWpGaD
Methantheline—CHRM1—GPCR downstream signaling—CASR—atherosclerosis	0.0012	0.0012	CbGpPWpGaD
Methantheline—HRH2—Signaling by GPCR—EDN1—atherosclerosis	0.00116	0.00116	CbGpPWpGaD
Methantheline—HRH2—Signaling by GPCR—CCL5—atherosclerosis	0.00115	0.00115	CbGpPWpGaD
Methantheline—CHRM1—Signaling by GPCR—UTS2—atherosclerosis	0.00114	0.00114	CbGpPWpGaD
Methantheline—CHRM1—GPCR downstream signaling—CNR2—atherosclerosis	0.00112	0.00112	CbGpPWpGaD
Methantheline—CHRM1—Class A/1 (Rhodopsin-like receptors)—F2—atherosclerosis	0.00111	0.00111	CbGpPWpGaD
Methantheline—CHRM1—GPCR ligand binding—EDN1—atherosclerosis	0.00111	0.00111	CbGpPWpGaD
Methantheline—HRH2—Signaling by GPCR—PRKCG—atherosclerosis	0.0011	0.0011	CbGpPWpGaD
Methantheline—CHRM1—GPCR ligand binding—CCL5—atherosclerosis	0.0011	0.0011	CbGpPWpGaD
Methantheline—HRH2—Signaling Pathways—VWF—atherosclerosis	0.00109	0.00109	CbGpPWpGaD
Methantheline—CHRM1—Regulation of Actin Cytoskeleton—MAPK3—atherosclerosis	0.00109	0.00109	CbGpPWpGaD
Methantheline—CHRM1—Signaling by GPCR—CX3CR1—atherosclerosis	0.00109	0.00109	CbGpPWpGaD
Methantheline—CHRM1—Signaling by GPCR—CASR—atherosclerosis	0.00109	0.00109	CbGpPWpGaD
Methantheline—HRH2—Signaling Pathways—APOC3—atherosclerosis	0.00109	0.00109	CbGpPWpGaD
Methantheline—HRH2—Signaling Pathways—LDLR—atherosclerosis	0.00108	0.00108	CbGpPWpGaD
Methantheline—CHRM1—Signaling by GPCR—CX3CL1—atherosclerosis	0.00107	0.00107	CbGpPWpGaD
Methantheline—HRH2—GPCR downstream signaling—AGT—atherosclerosis	0.00106	0.00106	CbGpPWpGaD
Methantheline—HRH2—Signaling Pathways—CCL3—atherosclerosis	0.00105	0.00105	CbGpPWpGaD
Methantheline—CHRM1—Signaling Pathways—HRH1—atherosclerosis	0.00104	0.00104	CbGpPWpGaD
Methantheline—CHRM1—Signaling by GPCR—CNR2—atherosclerosis	0.00101	0.00101	CbGpPWpGaD
Methantheline—HRH2—Signaling Pathways—NCF1—atherosclerosis	0.00101	0.00101	CbGpPWpGaD
Methantheline—CHRM1—Class A/1 (Rhodopsin-like receptors)—CCL2—atherosclerosis	0.000993	0.000993	CbGpPWpGaD
Methantheline—CHRM1—Circadian rythm related genes—MAPK8—atherosclerosis	0.000985	0.000985	CbGpPWpGaD
Methantheline—HRH2—GPCR downstream signaling—F2—atherosclerosis	0.000983	0.000983	CbGpPWpGaD
Methantheline—HRH2—Signaling by GPCR—AGT—atherosclerosis	0.000966	0.000966	CbGpPWpGaD
Methantheline—HRH2—Signaling Pathways—CCR2—atherosclerosis	0.000954	0.000954	CbGpPWpGaD
Methantheline—HRH2—Signaling Pathways—EDNRA—atherosclerosis	0.000954	0.000954	CbGpPWpGaD
Methantheline—HRH2—Signaling Pathways—CYBA—atherosclerosis	0.00095	0.00095	CbGpPWpGaD
Methantheline—HRH2—GPCR downstream signaling—PIK3CG—atherosclerosis	0.000941	0.000941	CbGpPWpGaD
Methantheline—HRH2—Signaling Pathways—PLAT—atherosclerosis	0.00093	0.00093	CbGpPWpGaD
Methantheline—HRH2—Signaling Pathways—PARP1—atherosclerosis	0.00093	0.00093	CbGpPWpGaD
Methantheline—HRH2—Signaling Pathways—GHRL—atherosclerosis	0.00093	0.00093	CbGpPWpGaD
Methantheline—CHRM1—GPCR ligand binding—AGT—atherosclerosis	0.000918	0.000918	CbGpPWpGaD
Methantheline—HRH2—Signaling by GPCR—F2—atherosclerosis	0.000893	0.000893	CbGpPWpGaD
Methantheline—CHRM1—Signaling by GPCR—CCL3—atherosclerosis	0.000871	0.000871	CbGpPWpGaD
Methantheline—CHRM1—GPCR downstream signaling—EDNRA—atherosclerosis	0.000867	0.000867	CbGpPWpGaD
Methantheline—CHRM1—GPCR downstream signaling—CCR2—atherosclerosis	0.000867	0.000867	CbGpPWpGaD
Methantheline—HRH2—Signaling by GPCR—PIK3CG—atherosclerosis	0.000854	0.000854	CbGpPWpGaD
Methantheline—CHRM1—GPCR ligand binding—F2—atherosclerosis	0.000849	0.000849	CbGpPWpGaD
Methantheline—CHRM1—GPCR downstream signaling—GHRL—atherosclerosis	0.000845	0.000845	CbGpPWpGaD
Methantheline—CHRM1—Signaling Pathways—APOA4—atherosclerosis	0.000818	0.000818	CbGpPWpGaD
Methantheline—HRH2—Signaling Pathways—KNG1—atherosclerosis	0.000816	0.000816	CbGpPWpGaD
Methantheline—CHRM1—Gastrin-CREB signalling pathway via PKC and MAPK—MAPK3—atherosclerosis	0.000815	0.000815	CbGpPWpGaD
Methantheline—HRH2—Signaling Pathways—AGTR1—atherosclerosis	0.000811	0.000811	CbGpPWpGaD
Methantheline—HRH2—Signaling by GPCR—CCL2—atherosclerosis	0.000796	0.000796	CbGpPWpGaD
Methantheline—HRH2—Signaling Pathways—PLG—atherosclerosis	0.00079	0.00079	CbGpPWpGaD
Methantheline—CHRM1—Signaling by GPCR—EDNRA—atherosclerosis	0.000788	0.000788	CbGpPWpGaD
Methantheline—CHRM1—Signaling by GPCR—CCR2—atherosclerosis	0.000788	0.000788	CbGpPWpGaD
Methantheline—CHRM1—Class A/1 (Rhodopsin-like receptors)—CXCL8—atherosclerosis	0.000785	0.000785	CbGpPWpGaD
Methantheline—CHRM1—Signaling by GPCR—GHRL—atherosclerosis	0.000768	0.000768	CbGpPWpGaD
Methantheline—CHRM1—GPCR ligand binding—CCL2—atherosclerosis	0.000756	0.000756	CbGpPWpGaD
Methantheline—CHRM1—Signaling Pathways—CCL4—atherosclerosis	0.000753	0.000753	CbGpPWpGaD
Methantheline—HRH2—Signaling Pathways—SOCS3—atherosclerosis	0.000749	0.000749	CbGpPWpGaD
Methantheline—CHRM1—GPCR downstream signaling—KNG1—atherosclerosis	0.000742	0.000742	CbGpPWpGaD
Methantheline—CHRM1—GPCR downstream signaling—AGTR1—atherosclerosis	0.000738	0.000738	CbGpPWpGaD
Methantheline—HRH2—Signaling Pathways—MMP3—atherosclerosis	0.000723	0.000723	CbGpPWpGaD
Methantheline—HRH2—Signaling Pathways—IGF2—atherosclerosis	0.00072	0.00072	CbGpPWpGaD
Methantheline—CHRM1—Signaling Pathways—APOA2—atherosclerosis	0.000704	0.000704	CbGpPWpGaD
Methantheline—HRH2—Signaling Pathways—APOB—atherosclerosis	0.000699	0.000699	CbGpPWpGaD
Methantheline—HRH2—GPCR downstream signaling—CXCL8—atherosclerosis	0.000693	0.000693	CbGpPWpGaD
Methantheline—HRH2—Signaling Pathways—EDN1—atherosclerosis	0.000688	0.000688	CbGpPWpGaD
Methantheline—HRH2—Signaling Pathways—CCL5—atherosclerosis	0.000682	0.000682	CbGpPWpGaD
Methantheline—CHRM1—Signaling by GPCR—KNG1—atherosclerosis	0.000674	0.000674	CbGpPWpGaD
Methantheline—CHRM1—Signaling Pathways—UTS2—atherosclerosis	0.000671	0.000671	CbGpPWpGaD
Methantheline—CHRM1—Signaling by GPCR—AGTR1—atherosclerosis	0.00067	0.00067	CbGpPWpGaD
Methantheline—HRH2—Signaling Pathways—LPL—atherosclerosis	0.000667	0.000667	CbGpPWpGaD
Methantheline—HRH2—Signaling Pathways—PRKCG—atherosclerosis	0.000649	0.000649	CbGpPWpGaD
Methantheline—CHRM1—Signaling Pathways—CX3CR1—atherosclerosis	0.000644	0.000644	CbGpPWpGaD
Methantheline—CHRM1—Signaling Pathways—CASR—atherosclerosis	0.000644	0.000644	CbGpPWpGaD
Methantheline—HRH2—Signaling Pathways—SPP1—atherosclerosis	0.000632	0.000632	CbGpPWpGaD
Methantheline—CHRM1—Signaling Pathways—CX3CL1—atherosclerosis	0.000631	0.000631	CbGpPWpGaD
Methantheline—HRH2—Signaling by GPCR—CXCL8—atherosclerosis	0.000629	0.000629	CbGpPWpGaD
Methantheline—CHRM1—Circadian rythm related genes—IL6—atherosclerosis	0.000629	0.000629	CbGpPWpGaD
Methantheline—CHRM1—GPCR downstream signaling—EDN1—atherosclerosis	0.000625	0.000625	CbGpPWpGaD
Methantheline—CHRM1—GPCR downstream signaling—CCL5—atherosclerosis	0.00062	0.00062	CbGpPWpGaD
Methantheline—CHRM1—Signaling Pathways—CNR2—atherosclerosis	0.000598	0.000598	CbGpPWpGaD
Methantheline—CHRM1—GPCR ligand binding—CXCL8—atherosclerosis	0.000598	0.000598	CbGpPWpGaD
Methantheline—CHRM1—Signaling by GPCR—MMP3—atherosclerosis	0.000597	0.000597	CbGpPWpGaD
Methantheline—CHRM1—Gastrin-CREB signalling pathway via PKC and MAPK—IL6—atherosclerosis	0.000596	0.000596	CbGpPWpGaD
Methantheline—CHRM1—GPCR downstream signaling—PRKCG—atherosclerosis	0.00059	0.00059	CbGpPWpGaD
Methantheline—HRH2—Signaling Pathways—PDGFB—atherosclerosis	0.000585	0.000585	CbGpPWpGaD
Methantheline—HRH2—Signaling Pathways—AGT—atherosclerosis	0.000571	0.000571	CbGpPWpGaD
Methantheline—CHRM1—Signaling by GPCR—EDN1—atherosclerosis	0.000568	0.000568	CbGpPWpGaD
Methantheline—CHRM1—Signaling by GPCR—CCL5—atherosclerosis	0.000563	0.000563	CbGpPWpGaD
Methantheline—HRH2—Signaling Pathways—LEP—atherosclerosis	0.000559	0.000559	CbGpPWpGaD
Methantheline—HRH2—Signaling Pathways—APOE—atherosclerosis	0.000559	0.000559	CbGpPWpGaD
Methantheline—HRH2—Signaling Pathways—CAV1—atherosclerosis	0.000554	0.000554	CbGpPWpGaD
Methantheline—HRH2—Signaling Pathways—APOA1—atherosclerosis	0.000553	0.000553	CbGpPWpGaD
Methantheline—CHRM1—Signaling by GPCR—PRKCG—atherosclerosis	0.000536	0.000536	CbGpPWpGaD
Methantheline—HRH2—Signaling Pathways—ESR1—atherosclerosis	0.000534	0.000534	CbGpPWpGaD
Methantheline—CHRM1—Signaling Pathways—VWF—atherosclerosis	0.000533	0.000533	CbGpPWpGaD
Methantheline—CHRM1—Signaling Pathways—APOC3—atherosclerosis	0.00053	0.00053	CbGpPWpGaD
Methantheline—HRH2—Signaling Pathways—F2—atherosclerosis	0.000527	0.000527	CbGpPWpGaD
Methantheline—CHRM1—Signaling Pathways—LDLR—atherosclerosis	0.000527	0.000527	CbGpPWpGaD
Methantheline—CHRM1—GPCR downstream signaling—AGT—atherosclerosis	0.000519	0.000519	CbGpPWpGaD
Methantheline—CHRM1—Signaling Pathways—CCL3—atherosclerosis	0.000515	0.000515	CbGpPWpGaD
Methantheline—HRH2—Signaling Pathways—PIK3CG—atherosclerosis	0.000505	0.000505	CbGpPWpGaD
Methantheline—CHRM1—Signaling Pathways—NCF1—atherosclerosis	0.000493	0.000493	CbGpPWpGaD
Methantheline—HRH2—Signaling by GPCR—MAPK3—atherosclerosis	0.000483	0.000483	CbGpPWpGaD
Methantheline—CHRM1—GPCR downstream signaling—F2—atherosclerosis	0.00048	0.00048	CbGpPWpGaD
Methantheline—HRH2—Signaling Pathways—INS—atherosclerosis	0.000478	0.000478	CbGpPWpGaD
Methantheline—CHRM1—Signaling by GPCR—AGT—atherosclerosis	0.000471	0.000471	CbGpPWpGaD
Methantheline—HRH2—Signaling Pathways—CCL2—atherosclerosis	0.00047	0.00047	CbGpPWpGaD
Methantheline—CHRM1—Signaling Pathways—EDNRA—atherosclerosis	0.000465	0.000465	CbGpPWpGaD
Methantheline—CHRM1—Signaling Pathways—CCR2—atherosclerosis	0.000465	0.000465	CbGpPWpGaD
Methantheline—CHRM1—Signaling Pathways—CYBA—atherosclerosis	0.000463	0.000463	CbGpPWpGaD
Methantheline—HRH2—Signaling Pathways—IGF1—atherosclerosis	0.000462	0.000462	CbGpPWpGaD
Methantheline—CHRM1—GPCR downstream signaling—PIK3CG—atherosclerosis	0.000459	0.000459	CbGpPWpGaD
Methantheline—CHRM1—Signaling Pathways—PLAT—atherosclerosis	0.000453	0.000453	CbGpPWpGaD
Methantheline—CHRM1—Signaling Pathways—PARP1—atherosclerosis	0.000453	0.000453	CbGpPWpGaD
Methantheline—CHRM1—Signaling Pathways—GHRL—atherosclerosis	0.000453	0.000453	CbGpPWpGaD
Methantheline—HRH2—Signaling Pathways—SERPINE1—atherosclerosis	0.000439	0.000439	CbGpPWpGaD
Methantheline—CHRM1—Signaling by GPCR—F2—atherosclerosis	0.000436	0.000436	CbGpPWpGaD
Methantheline—HRH2—Signaling Pathways—NOS3—atherosclerosis	0.000419	0.000419	CbGpPWpGaD
Methantheline—CHRM1—Signaling by GPCR—PIK3CG—atherosclerosis	0.000417	0.000417	CbGpPWpGaD
Methantheline—CHRM1—Signaling Pathways—KNG1—atherosclerosis	0.000398	0.000398	CbGpPWpGaD
Methantheline—CHRM1—Signaling Pathways—AGTR1—atherosclerosis	0.000396	0.000396	CbGpPWpGaD
Methantheline—CHRM1—Signaling by GPCR—CCL2—atherosclerosis	0.000388	0.000388	CbGpPWpGaD
Methantheline—CHRM1—Signaling Pathways—PLG—atherosclerosis	0.000386	0.000386	CbGpPWpGaD
Methantheline—HRH2—Signaling Pathways—CXCL8—atherosclerosis	0.000372	0.000372	CbGpPWpGaD
Methantheline—CHRM1—Signaling Pathways—SOCS3—atherosclerosis	0.000365	0.000365	CbGpPWpGaD
Methantheline—HRH2—GPCR downstream signaling—AKT1—atherosclerosis	0.000359	0.000359	CbGpPWpGaD
Methantheline—HRH2—Signaling by GPCR—IL6—atherosclerosis	0.000353	0.000353	CbGpPWpGaD
Methantheline—CHRM1—Signaling Pathways—MMP3—atherosclerosis	0.000353	0.000353	CbGpPWpGaD
Methantheline—CHRM1—Signaling Pathways—IGF2—atherosclerosis	0.000351	0.000351	CbGpPWpGaD
Methantheline—CHRM1—Signaling Pathways—APOB—atherosclerosis	0.000341	0.000341	CbGpPWpGaD
Methantheline—CHRM1—GPCR downstream signaling—CXCL8—atherosclerosis	0.000338	0.000338	CbGpPWpGaD
Methantheline—HRH2—Signaling Pathways—MMP9—atherosclerosis	0.000336	0.000336	CbGpPWpGaD
Methantheline—CHRM1—Signaling Pathways—EDN1—atherosclerosis	0.000335	0.000335	CbGpPWpGaD
Methantheline—CHRM1—Signaling Pathways—CCL5—atherosclerosis	0.000333	0.000333	CbGpPWpGaD
Methantheline—HRH2—Signaling Pathways—NFKB1—atherosclerosis	0.000333	0.000333	CbGpPWpGaD
Methantheline—HRH2—Signaling Pathways—MAPK8—atherosclerosis	0.000327	0.000327	CbGpPWpGaD
Methantheline—HRH2—Signaling by GPCR—AKT1—atherosclerosis	0.000326	0.000326	CbGpPWpGaD
Methantheline—CHRM1—Signaling Pathways—LPL—atherosclerosis	0.000325	0.000325	CbGpPWpGaD
Methantheline—CHRM1—Signaling Pathways—PRKCG—atherosclerosis	0.000316	0.000316	CbGpPWpGaD
Methantheline—CHRM1—Signaling Pathways—SPP1—atherosclerosis	0.000308	0.000308	CbGpPWpGaD
Methantheline—CHRM1—Signaling by GPCR—CXCL8—atherosclerosis	0.000307	0.000307	CbGpPWpGaD
Methantheline—HRH2—Signaling Pathways—VEGFA—atherosclerosis	0.000302	0.000302	CbGpPWpGaD
Methantheline—HRH2—Signaling Pathways—STAT3—atherosclerosis	0.000299	0.000299	CbGpPWpGaD
Methantheline—HRH2—Signaling Pathways—MAPK3—atherosclerosis	0.000286	0.000286	CbGpPWpGaD
Methantheline—CHRM1—Signaling Pathways—PDGFB—atherosclerosis	0.000285	0.000285	CbGpPWpGaD
Methantheline—CHRM1—Signaling Pathways—AGT—atherosclerosis	0.000278	0.000278	CbGpPWpGaD
Methantheline—HRH2—Signaling Pathways—TGFB1—atherosclerosis	0.000277	0.000277	CbGpPWpGaD
Methantheline—CHRM1—Signaling Pathways—APOE—atherosclerosis	0.000273	0.000273	CbGpPWpGaD
Methantheline—CHRM1—Signaling Pathways—LEP—atherosclerosis	0.000273	0.000273	CbGpPWpGaD
Methantheline—CHRM1—Signaling Pathways—CAV1—atherosclerosis	0.00027	0.00027	CbGpPWpGaD
Methantheline—CHRM1—Signaling Pathways—APOA1—atherosclerosis	0.00027	0.00027	CbGpPWpGaD
Methantheline—CHRM1—Signaling Pathways—ESR1—atherosclerosis	0.00026	0.00026	CbGpPWpGaD
Methantheline—CHRM1—Signaling Pathways—F2—atherosclerosis	0.000257	0.000257	CbGpPWpGaD
Methantheline—CHRM1—Signaling Pathways—PIK3CG—atherosclerosis	0.000246	0.000246	CbGpPWpGaD
Methantheline—CHRM1—Signaling by GPCR—MAPK3—atherosclerosis	0.000236	0.000236	CbGpPWpGaD
Methantheline—CHRM1—Signaling Pathways—INS—atherosclerosis	0.000233	0.000233	CbGpPWpGaD
Methantheline—CHRM1—Signaling Pathways—CCL2—atherosclerosis	0.000229	0.000229	CbGpPWpGaD
Methantheline—CHRM1—Signaling Pathways—IGF1—atherosclerosis	0.000225	0.000225	CbGpPWpGaD
Methantheline—CHRM1—Signaling Pathways—SERPINE1—atherosclerosis	0.000214	0.000214	CbGpPWpGaD
Methantheline—HRH2—Signaling Pathways—IL6—atherosclerosis	0.000209	0.000209	CbGpPWpGaD
Methantheline—CHRM1—Signaling Pathways—NOS3—atherosclerosis	0.000204	0.000204	CbGpPWpGaD
Methantheline—HRH2—Signaling Pathways—AKT1—atherosclerosis	0.000193	0.000193	CbGpPWpGaD
Methantheline—CHRM1—Signaling Pathways—CXCL8—atherosclerosis	0.000181	0.000181	CbGpPWpGaD
Methantheline—CHRM1—GPCR downstream signaling—AKT1—atherosclerosis	0.000175	0.000175	CbGpPWpGaD
Methantheline—CHRM1—Signaling by GPCR—IL6—atherosclerosis	0.000172	0.000172	CbGpPWpGaD
Methantheline—CHRM1—Signaling Pathways—MMP9—atherosclerosis	0.000164	0.000164	CbGpPWpGaD
Methantheline—CHRM1—Signaling Pathways—NFKB1—atherosclerosis	0.000162	0.000162	CbGpPWpGaD
Methantheline—CHRM1—Signaling Pathways—MAPK8—atherosclerosis	0.000159	0.000159	CbGpPWpGaD
Methantheline—CHRM1—Signaling by GPCR—AKT1—atherosclerosis	0.000159	0.000159	CbGpPWpGaD
Methantheline—CHRM1—Signaling Pathways—VEGFA—atherosclerosis	0.000147	0.000147	CbGpPWpGaD
Methantheline—CHRM1—Signaling Pathways—STAT3—atherosclerosis	0.000146	0.000146	CbGpPWpGaD
Methantheline—CHRM1—Signaling Pathways—MAPK3—atherosclerosis	0.000139	0.000139	CbGpPWpGaD
Methantheline—CHRM1—Signaling Pathways—TGFB1—atherosclerosis	0.000135	0.000135	CbGpPWpGaD
Methantheline—CHRM1—Signaling Pathways—IL6—atherosclerosis	0.000102	0.000102	CbGpPWpGaD
Methantheline—CHRM1—Signaling Pathways—AKT1—atherosclerosis	9.39e-05	9.39e-05	CbGpPWpGaD
